[{"address1": "3805 Old Easton Road", "city": "Doylestown", "state": "PA", "zip": "18902", "country": "United States", "phone": "617 463 9385", "website": "https://www.aprea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Oren  Gilad Ph.D.", "age": 56, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 796950, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John P. Hamill CPA", "age": 60, "title": "Senior VP, CFO, Principal Accounting Officer & Secretary", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 610230, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lars B. Abrahmsen Ph.D.", "age": 67, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Wiley", "age": 56, "title": "Senior Vice President of Corporate Development & Strategy", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michel  Afargan Ph.D.", "title": "Head of Pharmacology Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ze'ev  Weiss B.Sc., C.P.A.", "age": 62, "title": "Chief Business Advisor", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea  Epstein", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.53, "open": 3.44, "dayLow": 3.3698, "dayHigh": 3.63, "regularMarketPreviousClose": 3.53, "regularMarketOpen": 3.44, "regularMarketDayLow": 3.3698, "regularMarketDayHigh": 3.63, "beta": 1.462, "forwardPE": -3.7743158, "volume": 7796, "regularMarketVolume": 7796, "averageVolume": 29267, "averageVolume10days": 37130, "averageDailyVolume10Day": 37130, "marketCap": 19487376, "fiftyTwoWeekLow": 2.15, "fiftyTwoWeekHigh": 8.847, "priceToSalesTrailing12Months": 14.866339, "fiftyDayAverage": 3.59058, "twoHundredDayAverage": 3.791275, "currency": "USD", "enterpriseValue": -5451174, "floatShares": 3980251, "sharesOutstanding": 5434900, "sharesShort": 44890, "sharesShortPriorMonth": 10932, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0083, "heldPercentInsiders": 0.11744001, "heldPercentInstitutions": 0.42026, "shortRatio": 1.26, "shortPercentOfFloat": 0.0111, "impliedSharesOutstanding": 5434900, "bookValue": 4.038, "priceToBook": 0.8879643, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -13507166, "trailingEps": -2.8, "forwardEps": -1.02, "lastSplitFactor": "1:20", "lastSplitDate": 1676246400, "enterpriseToRevenue": -4.159, "enterpriseToEbitda": 0.37, "52WeekChange": -0.4378981, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "APRE", "underlyingSymbol": "APRE", "shortName": "Aprea Therapeutics, Inc.", "longName": "Aprea Therapeutics, Inc.", "firstTradeDateEpochUtc": 1570109400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "9a8f76c4-98d0-37f2-b77b-05a35baa6936", "messageBoardId": "finmb_329831339", "gmtOffSetMilliseconds": -18000000, "currentPrice": 3.5856, "targetHighPrice": 20.0, "targetLowPrice": 11.0, "targetMeanPrice": 15.66667, "targetMedianPrice": 16.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 26249624, "totalCashPerShare": 4.83, "ebitda": -14746663, "quickRatio": 7.22, "currentRatio": 7.284, "totalRevenue": 1310839, "revenuePerShare": 0.265, "returnOnAssets": -0.35056, "returnOnEquity": -0.60221, "grossProfits": -7739301, "freeCashflow": -9262926, "operatingCashflow": -13785472, "revenueGrowth": 0.11, "operatingMargins": -11.55322, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]